Phototherapy with narrowband vs broadband UVB

Acta Dermato-Venereologica

Volumn 85, Issue 2, 2005, Pages 98-108

  Berneburg, Mark ^a   Röcken, Martin ^a   Benedix, Frauke ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Broadband UVB; Narrowband UVB; Phototherapy; Psoriasis; Skin cancer; Ultraviolet light

Indexed keywords

CALCIPOTRIOL; COLECALCIFEROL DERIVATIVE; CYANOCOBALAMIN; CYCLOSPORIN A; DITHRANOL; ETRETIN; FOLIC ACID; METHOXSALEN; PSORALEN; STEROID; TACALCITOL; TAZAROTENE;

ATOPIC DERMATITIS; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SAFETY; SKIN DISEASE; TREATMENT INDICATION; ULTRAVIOLET RADIATION; VITILIGO;

HUMANS; PHOTOTHERAPY; SKIN DISEASES; ULTRAVIOLET RAYS;

EID: 16444373718     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510025579     Document Type: Review

References (148)

1. Goeckerman WH. The treatment of psoriasis. Northwest Med 1925; 24: 229-231.
2. Ingram JT. The approach to psoriasis. Br J Dermatol 1953; 2: 591-594.
3. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol 1976; 56: 383-390.
4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
5. van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
6. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-696.
7. Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol 1989; 69: 82-85.
8. Hoffmann K, Kaspar K, Altmeyer P, Gambichler T. UV transmission measurements of small skin specimens with special quartz cuvettes. Dermatology 2000; 201: 307-311.
9. Chadwick CA, Potten CS, Nikaido O, Matsunaga T, Proby C, Young AR. The detection of cyclobutane thymine dimers, (6-4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J Photochem Photobiol B 1995; 28: 163-170.
10. Campbell C, Quinn AG, Angus B, Farr PM, Rees JL. Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 1993; 53: 2697-2699.
11. Farr PM, Diffey BL, Steele MC. A preliminary study on the in vivo transmission of light through psoriatic plaques. Photodermatology 1984; 1: 87-90.
12. Wassberg C, Bâckvall H, Diffey B, Pontén F, Berne B. Enhanced epidermal ultraviolet responses in chronically sun-exposed skin are dependent on previous sun exposure. Acta Derm Venereol 2003; 83: 254-261.
13. Krutmann J, Morita A, Elmets A. Mechanisms of photo(chemo)therapy. In: Krutmann J, Honigsmann H, Elmets CA, Bergstresser PR, eds. Dermatological phototherapy and photodiagnostic methods. Berlin: Springer, 2001: 56-59.
14. Clingen PH, Arlett CF, Cole J, Waugh AP, Lowe JE, Harcourt SA, et al. Correlation of UVC and UVB cytotoxicity with the induction of specific photoproducts in T-lymphocytes and fibroblasts from normal human donors. Photochem Photobiol 1995; 61: 163-170.
15. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol 2001; 26: 573-577.
16. Dalziel KL. Aspects of cutaneous ageing. Clin Exp Dermatol 1991; 16: 315-323.
17. Berneburg M, Krutmann J. Photoimmunology, DNA repair and photocarcinogenesis. J Photochem Photobiol B 2000; 54: 87-93.
18. Berneburg M, Lowe JE, Nardo T, Araujo S, Fousteri MI. Green MH, et al. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J 2000; 19: 1157-1166.
19. Mathonnet G, Leger C, Desnoyers J, Drouin R, Therrien JP, Drobetsky EA. UV wavelength-dependent regulation of transcription-coupled nucleotide excision repair in p53-deficient human cells. Proc Natl Acad Sci USA 2003; 100: 7219-7224.
20. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987: 123: 241-250.
21. Berneburg M, Lehmann AR. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 2001; 43: 71-102.
22. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol 1999; 140: 995-1009.
23. El Ghorr AA, Norval M. Biological effects of narrowband (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B 1997; 38: 99-106.
24. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182: 2057-2068.
25. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189: 711-718.
26. Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses 2002; 58: 167-170.
27. Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1999; 40: 893-900.
28. Guckian M, Jones CD, Vestey JP, Cooper EJ, Dawe R, Gibbs NK, et al. Immunomodulation at the initiation of phototherapy and photochemotherapy. Photodermatol Photoimmunol Photomed 1995; 11: 163-169.
29. Laihia JK, Jansen CT. Urocanic acid photoconversion in relation to erythematogenicity of radiation from different types of phototherapy equipment. Photodermatol Photoimmunol Photomed 1994; 10: 13-16.
30. Barr RM, Walker SL, Tsang W, Harrison GI, Ettehadi P, Greaves MW, et al. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 1999; 112: 692-698.
31. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995; 154: 4851-4856.
32. Walters IB, Ozawa M, Cardinale I, Gilleaudeau P, Trepicchio WL, Bliss J, et al. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003; 139: 155-161.
33. Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-46.
34. Jones CD, Guckian M, El Ghorr AA, Gibbs NK, Norval M. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 1996; 12: 204-210.
35. Dawe RS, Cameron H, Yule S, Man I, Ibbotson SH, Ferguson J. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071-1076.
36. Gibbs NK. Narrowband UV-B phototherapy clears psoriasis through a combination of local and systemic effects. Arch Dermatol 2003; 139: 665-666.
37. Samson YS, Gielczyk R, Scherschun L, Lim HW. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol. Photomed 2003; 19: 164-168.
38. Leb wohl M. Should we switch from combination UVA/UVB phototherapy units to narrowband UVB? Photodermatol Photoimmunol Photomed 2002; 18: 44-46.
39. Feldman SR, Garton R, Averett W, Balkrishnan R, Vallee J. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother 2003; 4: 1525-1533.
40. Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133: 1514-1522.
41. Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, et al. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003; 148: 1194-1204.
42. Pasic A, Ceovic R, Lipozencic J, Husar K. Susie SM, Skerlev M, et al. Phototherapy in pediatric patients. Pediatr Dermatol 2003; 20: 71-77.
43. Diffey B. Towards optimal regimens for the UVB phototherapy of psoriasis: a mathematical model. Acta Derm Venereol 2004; 84: 259-264.
44. Snellman E, Klimenko T, Rantanen T. Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath plus UVA treatments for psoriasis. Acta Derm Venereol 2004; 84: 132-137.
45. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol 1999; 135: 519-524.
46. van Weelden H, Baart dlF, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990; 70: 212-215.
47. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139: 325-328.
48. Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-732.
49. Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 2002; 147: 973-978.
50. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998; 138: 833-839.
51. Wainwright NJ, Dawe RS, Ferguson J. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 1998; 139: 410-414.
52. Carrozza P, Hausermann P, Nestle FO, Burg G, Boni R. Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology 2000; 200: 35-39.
53. Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227-231.
54. van der Vleuten CJ, Gerritsen MJ, Steijlen PM, de Jong EM, van de Kerkhof PC. A therapeutic approach to erythrodermic psoriasis: report of a case and a discussion of therapeutic options. Acta Derm Venereol 1996; 76: 65-67.
55. Langner A, Ashton P, van de Kerkhof PC, Verjans H. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol 1996; 135: 385-389.
56. van de Kerkhof PC, Berth-Jones J, Griffiths CE, Harrison PV, Honigsmann H, Marks R, et al. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. Br J Dermatol 2002; 146: 414-422.
57. Fogh K, Kragballe K. Recent developments in vitamin D analogs. Curr Pharm Des 2000; 6: 961-972.
58. Bourke JF, Iqbal SJ, Hutchinson PE. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. Clin Exp Dermatol 1997; 22: 259-261.
59. Woo WK, McKenna KE. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol 2003; 149: 146-150.
60. Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 1993; 342: 923.
61. Rim JH, Choe YB, Youn JI. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients. Photodermatol Photoimmunol Photomed 2002; 18: 131-134.
62. Kragballe K. Vitamin D and UVB radiation therapy. Cutis 2002; 70: 9-12.
63. De Rie MA, Di Nuzzo S, Brands S, Hansen AB, Bos JD. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. Br J Dermatol 2000; 142: 1160-1165.
64. Lebwohl M, Quijije J, Gilliard J, Rollin T, Watts O. Topical calcitriol is degraded by ultraviolet light. J Invest Dermatol 2003; 121: 594-595.
65. Messer G, Degitz K, Plewig G, Röcken M. Pretreatment of psoriasis with the vitamin D3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br J Dermatol 2001; 144: 628-629.
66. Hofmann UB, Eggert AA, Brocker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. Br J Dermatol 2003; 148: 779-783.
67. Koo JY. Tazarotene in combination with phototherapy. J Am Acad Dermatol 1998; 39: S144-S148.
68. Behrens S, Grundmann-Kollmann M, Schiener R, Peter RU, Kerscher M. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol 2000; 42: 493-495.
69. Guenther LC. Optimizing treatment with topical tazarotene. Am J Clin Dermatol 2003; 4: 197-202.
70. Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol 2000; 43: 821-828.
71. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol 2000; 143: 1275-1278.
72. Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, et al. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol 2001; 45: 544-553.
73. Boer J, Schothorst AA, Boom B, Hermans J, Suurmond D. Influence of water and salt solutions on UVB irradiation of normal skin and psoriasis. Arch Dermatol Res 1982; 273: 247-259.
74. Gambichler T, Rapp S, Senger E, Altmeyer P, Hoffmann K. Balneophototherapy of psoriasis: highly concentrated salt water versus tap water - a randomized, one-blind, right/left comparative study. Photodermatol Photoimmunol Photomed 2001; 17: 22-25.
75. Schiffner R, Schiffner-Rohe J, Wolfl G, Landthaler M, Glassl A, Walther T, et al. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol 2000; 142: 740-747.
76. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127: 5-9.
77. Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatol Treat 2003; 14(Suppl 2): 17-20.
78. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3: 513-526.
79. van de Kerkhof PC, de Rooij MJ. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. Br J Dermatol 1997; 136: 275-278.
80. Bavinck JN, Tieben LM, Van der Woude FJ, Tegzess AM, Hermans J, ter Schegget J, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13: 1933-2938.
81. Nijsten TE, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2003; 49: 644-650.
82. de Berker DA, Sakuntabhai A, Diffey BL, Matthews JN, Farr PM. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol 1997; 36: 577-581.
83. Ortel B, Perl S, Kinaciyan T, Calzavara-Pinton PG, Honigsmann H. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 1993; 29: 736-740.
84. Sakuntabhai A, Diffey BL, Farr PM. Response of psoriasis to psoralen-UVB photochemotherapy. Br J Dermatol 1993; 128: 296-300.
85. Calzavara-Pinton P. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination. J Am Acad Dermatol 1998; 38: 687-690.
86. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132: 956-963.
87. Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996; 135: 332.
88. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000; 142: 39-43.
89. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001; 357: 2012-2016.
90. Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003; 139: 223-224.
91. Brazzelli V, Prestinari F, Chiesa MG, Borroni RG, Ardigo M, Borroni G. Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy. Dermatology 2002; 204: 252-254.
92. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-1380.
93. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-197.
94. Diederen PV, van Weelden H, Sanders CJ, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48: 215-219.
95. Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW. et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995; 33: 234-242.
96. Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 2000; 136: 748-752.
97. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, et al. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999; 112: 317-321.
98. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
99. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
100. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369-372.
101. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo. Metaanalysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
102. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
103. Buckley DA, Rogers S. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 1996; 21: 43-45.
104. Takeda H, Mitsuhashi Y, Kondo S. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol 1998; 38: 268-270.
105. Kaptanoglu AF, Oskay T. Ultraviolet B treatment for pruritus in Hodgkin's lymphoma. J Eur Acad Dermatol Venereol 2003; 17: 489-490.
106. Hsu MM, Yang CC. Uraemic pruritus responsive to broadband ultraviolet (UV) B therapy does not readily respond to narrowband UVB therapy. Br J Dermatol 2003; 149: 888-889.
107. Baldo A, Sammarco E, Plaitano R, Martinelli V, Monfrecola G. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol 2002; 147: 979-981.
108. Ferrandiz C, Carrascosa JM, Just M, Bielsa I, Ribera M. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis. Dermatology 1997; 195: 359-361.
109. Fesq H, Ring J, Abeck D. Management of polymorphous light eruption: clinical course, pathogenesis, diagnosis and intervention. Am J Clin Dermatol 2003; 4: 399-406.
110. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
111. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42: 208-213.
112. Warren LJ, George S. Erythropoietic protoporphyria treated with narrow-band (TL-01) UVB phototherapy. Australas J Dermatol 1998; 39: 179-182.
113. Dummer R, Ivanova K, Scheidegger EP, Burg G. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology 2003; 207: 93-95.
114. Grundmann-Kollmann M, Martin H, Ludwig R, Klein S, Boehncke WH, Hoelzer D, et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 2002; 74: 1631-1634.
115. Luftl M, Degitz K, Plewig G, Röcken M. Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 1997; 133: 1597-1603.
116. Cameron H, Dawe RS. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with narrowband (TL-01) UVB phototherapy. Br J Dermatol 1997; 137: 150-151.
117. Orton DI, George SA. Subcorneal pustular dermatosis responsive to narrowband (TL-01) UVB phototherapy. Br J Dermatol 1997; 137: 149-150.
118. Bayramgurler D, Apaydin R, Cetiner D, Zincirci C. Narrow-band ultraviolet B phototherapy for acquired perforating dermatosis. Australas J Dermatol 2003; 44: 76-78.
119. Reed J, George S. Pruritic folliculitis of pregnancy treated with narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1999; 141: 177-179.
120. Kirby B, Watson R. Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01). Br J Dermatol 2000; 142: 376-377.
121. Khoo L, Asawanonda P, Grevelink SA, Taylor CR. Narrow-band UVB-associated lesional blisters in pityriasis rubra pilaris. J Am Acad Dermatol 1999; 41: 803-804.
122. Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol 2002; 41: 282-283.
123. Saricaoglu H, Karadogan SK, Baskan EB, Tunali S. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed 2003; 19: 265-267.
124. Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143: 964-968.
125. Man I, Dawe RS, Ferguson J, Ibbotson SH. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. Photochem Photobiol 2003; 78: 55-60.
126. Farr PM, Besag JE, Diffey BL. The time course of UVB and UVC erythema. J Invest Dermatol 1988; 91: 454-457.
127. Gloor M, Scherotzke A. Age dependence of ultraviolet light-induced erythema following narrow-band UVB exposure. Photodermatol Photoimmunol Photomed 2002; 18: 121-126.
128. Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed 2000; 16: 239-244.
129. Scharffetter-Kochanek K, Brenneisen P, Wenk J, Herrmann G, Ma W, Kuhr L. et al. Photoaging of the skin from phenotype to mechanisms. Exp Gerontol 2000; 35: 307-316.
130. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138: 1462-1470.
131. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156-1161.
132. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994; 73: 2759-2764.
133. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol 2004; 121: 252-258.
134. Pittelkow MR, Perry HO, Muller SA, Maughan WZ, O'Brien PC. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol 1981; 117: 465-468.
135. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994; 10: 192-197.
136. Gibbs NK, Traynor NJ, MacKie RM, Campbell I, Johnson BE, Ferguson J. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995; 104: 359-363.
137. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol 1991; 71: 245-248.
138. Fischer T, Alsins J, Berne B. Ultraviolet-action spectrum and evaluation of ultraviolet lamps for psoriasis healing. Int J Dermatol 1984; 23: 633-637.
139. Cole CA, Forbes PD, Davies RE. An action spectrum for UV photocarcinogenesis. Photochem Photobiol 1986; 43: 275-284.
140. Sterenborg HJ, van Weelden H, van der Leun JC. The dose-response relationship for tumourigenesis by UV radiation in the region 311-312 nm. J Photochem Photobiol B 1988; 2: 179-194.
141. Macve JC, Norval M. The effects of UV waveband and cis-urocanic acid on tumour outgrowth in mice. Photochem Photobiol Sci 2002; 1: 1006-1011.
142. Enninga IC, Groenendijk RT, Filon AR, van Zeeland AA, Simons JW. The wavelength dependence of UV-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts. Carcinogenesis 1986; 7: 1829-3186.
143. Tzung TY, Runger TM. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol 1998; 67: 647-650.
144. Budiyanto A, Ueda M, Ueda T, Ichihashi M. Formation of cyclobutane pyrimidine dimers and 8-oxo-7,8-dihydro-2′-deoxyguanosine in mouse and organ-cultured human skin by irradiation with broad-band or with narrowband UVB. Photochem Photobiol 2002; 76: 397-400.
145. An appraisal of narrowband (TL-01) UVB phototherapy, British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997; 137: 327-330.
146. de Gruijl FR. Photobiology of photocarcinogenesis. Photochem Photobiol 1996; 63: 372-375.
147. Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broad band or narrow band UVB phototherapy: a first retrospective study. Acta Derm Venereol 2004; 84: 370-374.
148. Hjerppe M, Hasan T, Saksala I, Reunala T. Narrowband UVB treatment in atopic dermatitis. Acta Derm Venereol 2001; 81: 439-440.